DELTA - A Randomized Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer
Randomized patients receive either standard of care or standard of care plus DLT (five
massage sessions per week for 4 consecutive weeks). Primary evaluation of all patients is
recorded six weeks after randomization by measuring the affected limb and comparing with the
unaffected one. There is an extended follow-up of one year.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Percent reduction in excess arm volume as calculated from circumferential arm measurements
at 6 weeks
Yes
Ian Dayes, MD
Study Director
Ontario Clinical Oncology Group (OCOG)
Canada: Ethics Review Committee
CBCRA- 013260
NCT00201890
March 2003
February 2010
Name | Location |
---|